Live courses

Title Credit Cost Dates
Monthly Oncology Tumor Boards: Uveal Melanoma: Treatment of Metastatic Disease
    • 1.00 CCM clock hours
    • 1.00 ANCC contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ACPE contact hours
    • 1.00 AAPA Category 1 CME credit
    • 1.00 Participation
$0.00 04/10/2023 - 3:00pm to 4:00pm EDT
Monthly Oncology Tumor Boards: Management of Relapsed/Refractory Mantle Cell Lymphoma
    • 1.00 CCM clock hours
    • 1.00 ANCC contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ACPE contact hours
    • 1.00 AAPA Category 1 CME credit
    • 1.00 Participation
$0.00 04/18/2023 - 3:15pm to 4:15pm EDT
Monthly Oncology Tumor Boards: Adjuvant Therapy for Patients with Resectable Early-Stage and Locally Advanced Non-Small Cell Lung Cancer
    • 1.00 CCM clock hours
    • 1.00 ANCC contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ACPE contact hours
    • 1.00 AAPA Category 1 CME credit
    • 1.00 Participation
$0.00 05/16/2023 - 12:45pm to 1:45pm EDT
NCCN Pharmacy Updates: Changing Treatment Paradigms in Chronic Lymphocytic Leukemia
    • 1.00 ANCC contact hours
      • 1.00 ANCC Pharmacology Contact Hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ACPE contact hours
    • 1.00 AAPA Category 1 CME credit
    • 1.00 Participation
$0.00 05/24/2023 - 1:00pm to 2:00pm EDT
NCCN Pharmacy Updates: The Role of PD-L1 Therapy in the Early Treatment of Triple Negative Breast Cancer
    • 1.00 ANCC contact hours
      • 1.00 ANCC Pharmacology Contact Hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ACPE contact hours
    • 1.00 AAPA Category 1 CME credit
    • 1.00 Participation
$0.00 05/31/2023 - 10:00am to 11:00am EDT

Pages

Featured Online Courses

Title Credit Type Event date Cost
Acute Myeloid Leukemia: Reviewing Current Best Practice and Exploring Novel Paradigms Ahead
    • 2.00 ANCC contact hours
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 ACPE contact hours
    • 2.00 AAPA Category 1 CME credit
    • 2.00 Participation
Enduring $0.00
Application of the Latest Data in CLL/SLL: Guidance for Current and Future Treatment Strategies
    • 2.00 ANCC contact hours
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 ACPE contact hours
    • 2.00 AAPA Category 1 CME credit
    • 2.00 Participation
Enduring $0.00
Clinical Considerations in Renal Cell Carcinoma: Current Evidence, Guideline Recommendations, and a View to the Future
    • 2.00 ANCC contact hours
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 ACPE contact hours
    • 2.00 AAPA Category 1 CME credit
    • 2.00 Participation
Enduring $0.00
New and Notable Clinical Data and Guideline Updates on Systemic Therapies in Hepatocellular Carcinoma
    • 1.00 ANCC contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ACPE contact hours
    • 1.00 AAPA Category 1 CME credit
    • 1.00 Participation
Enduring $0.00

Transcript

Please login or create an account to view your activities.

Pending Activities

Please login or create an account to view your activities.